Clinical Trials in San Diego

Showing 9441-9460 of 12,589 trials

A Novel Method to Determine HIV Incidence Among Youth

NCT00103883

Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective interventions to disease progression and improve outcome. This study will develop and evaluate a saliva-based sensitive/less sensitive (S/LS) assay for differentiating persons with recent HIV-1 infection (less than 133 days) from those with established HIV-1 infection.

HIV Infection

University of North Carolina, Chapel Hill440 participantsStarted Feb 2003

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDPhase 4< 1 mile

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

NCT00068809

This study will determine if taking anti-HIV drugs 4 days a week will control HIV-1 viral replication in patients who have already had at least 6 months of documented viral suppression with full-time treatment. If this strategy is shown to be safe in this study, a larger study will be undertaken to determine if the strategy can decrease overall drug exposure and help young people adjust more easily to a chronic medication schedule.

HIV Infections

University of North Carolina, Chapel Hill31 participantsStarted Jul 2003

Los Angeles, California, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +6 more locations

A Novel Method to Determine HIV Incidence Among Youth

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Find Trials by Condition in San Diego

A Slit Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel for Rejuvenation of the Cheek

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

C2P Mobilization Intervention (Pilot)

Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

CDC-ATN Linkage Evaluation

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Immunologic Memory (Supp. of ATN 024)

Factors Affecting PrEP Adherence

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Treatment De-Intensification and Residual HIV-1 in Youth

HIV Treatment-Readiness Measure (HTRM) Validation

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Linkage to Care - Part II

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery